Israel-headquartered Oramed Pharmaceutical is developing its own oral insulin ORMD-0801, and presented data from a phase 2b trial in San Diego. Other companies are looking to administer insulin ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

BISMARCK, N.D. (North Dakota Monitor) – The North Dakota House of Representatives voted 59-27 on Thursday for a bill to lower ...

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

and shifted the cost of high insulin list prices to vulnerable patients.” Together, the three PBMs administer roughly 80% of all prescriptions in America. Drugmakers offer discounts to PBMs to ...

On average, MDI users administer insulin four times daily a routine that 14% of participants said doesn't align well with their lifestyle. Moreover, 24% of participants mentioned that transporting ...

Until they know for sure, they may give them insulin. Once they confirm it's type 2 diabetes, they’ll ask you to help them make lifestyle changes. They may suggest they take a medication called ...

and shifted the cost of high insulin list prices to vulnerable patients.” Together, the three PBMs administer roughly 80% of all prescriptions in America. Drugmakers offer discounts to PBMs to gain ...